News

Whales with a lot of money to spend have taken a noticeably bullish stance on Cardinal Health. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened ...
Cencora COR saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 78. Please watch ...
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that ...
Readers hoping to buy Cencora, Inc. (NYSE:COR) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business day before a ...
CAH is scheduled to report fourth-quarter fiscal 2025 results on Aug. 12, before market open. In the last reported quarter, ...
Bloomberg's large-cap BMVP portfolio delivered positive returns in 2Q but trailed its benchmarks, held back by its defensive tilt during one of the fastest market rebounds on record.
Cencora, Inc. earns a Buy rating with a $337 fair value. Learn how its specialty drug focus and strategic investments drive ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Cencora’s forward-looking guidance remains optimistic, with expectations of substantial growth. The company anticipates a 15% to 16% increase in adjusted diluted EPS and consolidated operating income.
Q3 2025 Earnings Call Transcript August 6, 2025 Cencora, Inc. beats earnings expectations. Reported EPS is $4, expectations were $3.85. Operator: Hello, everyone, and thank you for joining the Cencora ...
As of fiscal year-end 2025, McKesson held cash and cash equivalents of $5.7 billion with outstanding debt at $4.4 billion. Roughly one third of its debt is due to mature over the next three years, and ...
Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the ...